VERA — Vera Therapeutics Share News
0.000.00%
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial
U.S. RESEARCH ROUNDUP-Fedex Freight Holding Company, PDF Solutions, Robinhood Markets
Vera rises on early kidney function data in FDA review
Vera Therapeutics Q2 loss widens less than expected
Brief: US FDA Approves Trutakna For Proteinuria In Primary Immunoglobulin A Nephropathy
Vera climbs as FDA approves kidney disease drug
US FDA approves Vera's kidney disease drug (updated)
US FDA approves Vera's kidney disease drug
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
U.S. STOCKS ON THE MOVE-Dollar General, Vera, Amtech Systems
Vera rises as FDA agrees to review late-stage kidney drug data for full approval
Brief: Vera Therapeutics announces inducement grants under Nasdaq listing rule 5635(C)(4)
Vera Therapeutics Q1 net loss widens
Brief: Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Vera Therapeutics Appoints Jane Wright-Mitchell As Chief Legal Officer